Sitagliptin (Januvia): Effect, Dosage & Side Effects

Take sitagliptin safely – with brite

Intake reminder, interaction check and your medication plan in one place. Free of charge.

At a glance: fact sheet
How sitagliptin works
Use & dosage
Where it fits in the treatment plan
Sitagliptin vs. other diabetes medicines
Side effects
Interactions
How brite supports you
FAQ
Sources

Never stop taking sitagliptin on your own. Leaving it out independently can cause your blood sugar to spiral out of control – always discuss changes to your diabetes therapy with your practice.

1. At a glance: fact sheet

Sitagliptin (brand name Januvia®) is a tablet-form active substance for the treatment of type 2 diabetes. It belongs to the group of DPP-4 inhibitors, colloquially known as "gliptins". Its big advantage in everyday life: sitagliptin lowers blood sugar without itself triggering hypoglycaemia, and is usually well tolerated.

Property	Details
Active substance	Sitagliptin
Brand name	Januvia®
ATC code	A10BH01
Drug class	DPP-4 inhibitor (gliptin)
Formulation	Film-coated tablets 25, 50, 100 mg
Intake	Once daily, independent of meals
Standard dose	100 mg/day (reduced in renal impairment)
Prescription required	Yes
Special feature	Barely any hypoglycaemia, weight-neutral

Table scrollable to the right

2. How sitagliptin works

After eating, the gut releases messenger substances known as incretins (above all GLP-1). They stimulate the pancreas to release insulin and, at the same time, curb glucagon, the hormone that raises blood sugar. Normally these incretins are broken down very quickly by the enzyme DPP-4.

This is exactly where sitagliptin comes in: it inhibits the enzyme DPP-4, so that the body's own incretins stay active for longer. The result is a blood-sugar-dependent effect – insulin is released mainly when blood sugar rises after eating. When sugar falls, the insulin stimulus subsides too. Because the medicine does not "drive" the pancreas permanently, hypoglycaemia is barely a risk and, as a rule, there is no weight gain. Sitagliptin is used in type 2 diabetes, usually as an add-on when diet, exercise and metformin alone are not enough.

3. Use & dosage

The standard dose is 100 mg once daily, independent of meals and ideally at the same time each day. Because sitagliptin is excreted predominantly via the kidneys, the dose is based on kidney function.

Situation	Dose
Normal to mildly reduced kidney function	100 mg once/day
Moderately reduced kidney function	50 mg once/day
Severely reduced kidney function / dialysis	25 mg once/day
Missed dose	Take as soon as you notice – never double up

Table scrollable to the right

Keep an eye on kidney function Since the dose depends on kidney function, your practice checks it regularly – especially in older people. If kidney function changes, an adjustment of the sitagliptin dose may be necessary. This decision is always made by the doctor.

A missed dose is taken as soon as you notice – but never a double amount on one day. What generally applies to a missed dose is explained in the guide Diabetes medicines in everyday life.

Never miss a dose again

brite reliably reminds you of your daily sitagliptin intake and documents it seamlessly.

Daily intake reminder
Seamless documentation
Interactions at a glance

Set up reminder

4. Where it fits in the treatment plan

In type 2 diabetes, treatment follows a step-by-step plan. The basis is always diet and exercise, usually together with metformin. If that is not enough to bring long-term blood sugar (HbA1c) to target, a second medicine is added. Sitagliptin is one such add-on – especially when hypoglycaemia and weight gain are to be avoided.

Compared with the sulphonylurea glimepiride, sitagliptin has a considerably lower risk of hypoglycaemia and is weight-neutral. Against the SGLT2 inhibitor empagliflozin, sitagliptin scores with very good tolerability, but – unlike empagliflozin – has no proven additional benefit for the heart and kidneys. Which combination fits best depends on comorbidities, weight and kidney function.

5. Sitagliptin vs. other diabetes medicines

For everyday life, three questions are above all decisive: Is there a risk of hypoglycaemia? Do you gain weight? And how good is the tolerability? The following table places sitagliptin in relation to frequently combined active substances.

Property	Sitagliptin	Metformin	Glimepiride	Empagliflozin
Class	DPP-4 inhibitor	Biguanide	Sulphonylurea	SGLT2 inhibitor
Hypoglycaemia	Barely	Barely	Yes, possible	Barely
Weight	Neutral	Neutral to slightly lowering	Rather gain	Rather lowering
Intake	Once daily	Once to twice daily	Once daily	Once daily
Special feature	Very well tolerated	Base medicine	Strong effect, but hypo risk	Protects heart & kidneys

Table scrollable to the right

None of these medicines is categorically "the best". Sitagliptin is a particularly good choice when a well-tolerated add-on without hypoglycaemia risk is sought. The selection is made individually by the doctor.

6. Side effects

Sitagliptin is considered well tolerated. Taken on its own, it barely triggers hypoglycaemia. Most side effects are mild – what matters is knowing the rare but serious warning signs.

Side effect	Frequency	What to do?
Headache, cold symptoms	Common	Usually harmless; mention if frequent
Nausea, feeling of fullness, constipation	Occasional	Observe; investigate if persistent
Hypoglycaemia (esp. with sulphonylurea/insulin)	Occasional	Measure sugar, take fast carbohydrates
Skin rash, allergic reaction	Rare	Have it medically assessed
Inflammation of the pancreas (pancreatitis)	Rare	Seek medical assessment immediately

Table scrollable to the right

Warning signs of pancreatitis – seek medical assessment Persistent, severe upper abdominal pain radiating in a belt-like fashion into the back, often together with nausea and vomiting. In this case do not continue taking sitagliptin and seek medical help immediately – for very severe symptoms call the emergency number 112.

7. Interactions

Sitagliptin has comparatively few interactions. What matters most is the combination with other blood-sugar-lowering agents. Check your combinations in the interaction check.

Sitagliptin + glimepiride or insulin In combination with a sulphonylurea such as glimepiride or with insulin, the risk of hypoglycaemia rises considerably. In such cases the practice often lowers the dose of the partner medicine. Watch for signs such as trembling, sweating and ravenous hunger.

Substance / medicine	Interaction	Recommendation
Sulphonylureas (glimepiride), insulin	Increased risk of hypoglycaemia	Lower the partner's dose if needed
Metformin	Combines well, often a fixed combination tablet	Standard combination, well tolerated
Digoxin	Slightly raised digoxin level	Monitor if necessary
Other diabetes medicines	Additive blood-sugar lowering	Combine only according to a medical plan

Table scrollable to the right

Manage your diabetes safely in everyday life

With brite you have your medication plan and your readings ready for every doctor's visit.

Create medication plan

Transparency note brite is a health app. The following functions refer to features of the app.

8. How brite supports you with sitagliptin

Intake reminder: daily reminder at a fixed time – so the once-daily intake reliably becomes routine. → Set up reminder
Interaction check: detects critical combinations such as sitagliptin + sulphonylurea. → Check now
Digital medication plan: all diabetes medicines clearly laid out for the practice and for emergencies. → To the medication plan
Health history: document blood sugar readings and how you feel, and bring them to your appointment.

FAQ: Common questions about sitagliptin

When is the best time to take sitagliptin?

Once daily at roughly the same time, independent of meals. So you can take the tablet in the morning or in the evening – choose the time that fits best into your daily routine. A fixed routine and a reminder help you not to forget a dose.

Why does sitagliptin barely cause hypoglycaemia?

Sitagliptin works in a blood-sugar-dependent way: it promotes insulin release mainly when blood sugar rises after eating. When sugar falls, the stimulus subsides. That is why, taken on its own, it barely poses a risk of hypoglycaemia – unlike sulphonylureas such as glimepiride.

Do you gain weight from sitagliptin?

No, sitagliptin is considered weight-neutral and as a rule leads neither to weight gain nor weight loss. That sets it apart from some other diabetes medicines. Anyone who actively wants to lose weight should talk to their practice about active substances such as SGLT2 inhibitors.

What is the difference between sitagliptin and metformin?

Metformin is usually the base medicine in type 2 diabetes. Sitagliptin is often the add-on when metformin alone is not enough. The two combine well, often even as a fixed combination tablet. Which order is right is determined by the practice.

Does the dose need to be adjusted in renal impairment?

Yes. Since sitagliptin is excreted predominantly via the kidneys, the dose is reduced in reduced kidney function – from 100 mg to 50 or 25 mg daily. The practice therefore checks the kidney values regularly and adjusts the dose if needed.

How do I recognise inflammation of the pancreas?

Typical are persistent, severe upper abdominal pain radiating in a belt-like fashion into the back, often with nausea and vomiting. This rare side effect is serious: in that case do not continue taking sitagliptin and seek medical help immediately, for very severe symptoms via the emergency number 112.

May I simply stop taking sitagliptin when I feel well?

No, not on your own. Even if you feel well, sitagliptin keeps your blood sugar in check. Leaving it out can let sugar rise again. Changes to your diabetes therapy – for example when readings are good – are always discussed by the treating practice.

Support your diabetes safely – with brite

Intake reminder, interaction check and medication plan. Free of charge.

Track sitagliptin

Sources

Prescribing information Januvia® (sitagliptin), current version.
National Disease Management Guideline (NVL) Type 2 Diabetes / German Diabetes Society (DDG). leitlinien.de
Gelbe Liste: Sitagliptin. gelbe-liste.de
gesundheitsinformation.de (IQWiG): Medicines for type 2 diabetes. gesundheitsinformation.de

Medical disclaimer: This page is for information and does not replace medical advice. Never stop taking sitagliptin on your own. In the event of persistent severe upper abdominal pain radiating into the back, nausea and vomiting (suspected pancreatitis), seek medical help immediately; for very severe symptoms call the emergency number 112. Status: July 2026.